MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements

Blood

Volumn 119, Issue 26, 2012, Pages

  Granados, Diana Paola ^a,b   Yahyaoui, Wafaa ^a,b   Laumont, Céline M ^a,b   Daouda, Tariq ^a,b   Muratore Schroeder, Tara L ^a,b   Côté, Caroline ^a   Laverdure, Jean Philippe ^a   Lemieux, Sébastien ^a,b   Thibault, Pierre ^a,b   Perreault, Claude ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ASSOCIATED PEPTIDE; MICRORNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA STRUCTURE; HUMAN; HUMAN CELL; MIRNA RESPONSE ELEMENT; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; STRUCTURE ANALYSIS;

EID: 84863509993     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-412593     Document Type: Article

References (49)

1. Perreault C, Decary F, Brochu S, Gyger M, Belanger R, Roy D. Minor histocompatibility antigens. Blood. 1990;76(7):1269-1280. (Pubitemid 20342739)
2. Boehm T. Quality control in self/nonself discrimination. Cell. 2006;125(5):845-858. (Pubitemid 44208883)
3. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009;9(12):833-844.
4. Perreault C. The origin and role of MHC class I-associated self-peptides. Prog Mol Biol Transl Sci. 2010;92:41-60.
5. de Verteuil D, Granados DP, Thibault P, Perreault C. Origin and plasticity of MHCI-associated self peptides [published online ahead of print, November 12, 2011]. Autoimmun Rev. doi:10.1016/j.autrev.2011.11.003.
6. McPhee CG, Sproule TJ, Shin DM et al. MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J Immunol. 2011;187(9):4695-4704.
7. Horton R, Wilming L, Rand V et al. Gene map of the extended human MHC. Nat Rev Genet. 2004; 5(12):889-899. (Pubitemid 39564252)
8. Sidney J, Peters B, Frahm N, Brander C, Sette A. HLAclass I supertypes: a revised and updated classification. BMC Immunol. 2008;9:1.
9. Mester G, Hoffmann V, Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci. 2011;68:1521-1532.
10. Yewdell JW, Reits E, Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol. 2003;3(12): 952-961. (Pubitemid 37521537)
11. Neefjes J, Jongsma MLM, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11(12):823-836.
12. Dolan BP, Bennink JR, Yewdell JW. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci. 2011;68(9):1481-1489.
13. Yewdell JW. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 2011;32(11):548-558.
14. Yewdell JW, Lacsina JR, Rechsteiner MC, Nicchitta CV. Out with the old, in with the new? Comparing methods for measuring protein degradation. Cell Biol Int. 2011;35(5):457-462.
15. Milner E, Barnea E, Beer I, Admon A. The turnover kinetics of MHC peptides of human cancer cells. Mol Cell Proteomics. 2006;5(2):357-365. (Pubitemid 43329313)
16. Fortier MH, Caron E, Hardy MP, et al. The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med. 2008;205(3):595-610. (Pubitemid 351439307)
17. de Verteuil D, Muratore-Schroeder TL, Granados DP, et al. Deletion of immunoproteasome sub-units imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol Cell Proteomics. 2010;9(9):2034-2047.
18. Caron E, Vincent K, Fortier MH, et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol. 2011;7:533.
19. Hickman HD, Luis AD, Buchli R, et al. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol. 2004; 172(5):2944-2952. (Pubitemid 38263681)
20. Tosato G, Cohen JI. Generation of Epstein-Barr virus (EBV)-immortalized B cell lines. Curr Protoc Immunol. 2007;Chapter 7:Unit 7.22.
21. Courcelles M, Lemieux S, Voisin L, Meloche S, Thibault P. ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses. Proteomics. 2011;11(13):2654- 2671.
22. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 2008;36(Web Server issue):W509-W512.
23. Nielsen M, Lundegaard C, Blicher T, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One. 2007;2(8): e796.
24. Vita R, Zarebski L, Greenbaum JA, et al. The immune epitope database 2.0. Nucleic Acids Res. 2010;38(Database issue):D854-D862.
25. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20. (Pubitemid 40094598)
26. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550. (Pubitemid 41528093)
27. Weinzierl AO, Lemmel C, Schoor O, et al. Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics. 2007;6(1):102-113. (Pubitemid 46152695)
28. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005; 33(Web Server issue):W741-W748.
29. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004; 20(9):1453-1454. (Pubitemid 38931415)
30. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics. 2004; 20(17):3246-3248. (Pubitemid 39619217)
31. Peters B, Bui HH, Frankild S, et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol. 2006;2(6):e65.
32. Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 2008;9:8.
33. Choi EY, Christianson GJ, Yoshimura Y, et al. Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus- host disease. Blood. 2002;100(13):4259-4264.
34. Mullally A, Ritz J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood. 2007;109(4): 1355-1362. (Pubitemid 46239565)
35. Vincent K, Roy DC, Perreault C. Next-generation leukemia immunotherapy. Blood. 2011;118(11): 2951-2959.
36. Li N, Matte-Martone C, Zheng H, et al. Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improves GVL and immune reconstitution. Blood. 2011; 118(22):5965-5976.
37. Toung JM, Morley M, Li M, Cheung VG. RNA-sequence analysis of human B-cells. Genome Res. 2011;21(6):991-998.
38. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233.
39. Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ. T cells as a self-referential, sensory organ. Annu Rev Immunol. 2007;25:681- 695.
40. Herbeck JT, Gottlieb GS, Wong K, et al. Fidelity of SNP array genotyping using Epstein Barr virus-transformed B-lymphocyte cell lines: implications for genome-wide association studies. PLoS One. 2009;4(9):e6915.
41. Bleakley M, Otterud BE, Richardt JL, et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood. 2010;115(23):4923-4933.
42. Gu W, Cochrane M, Leggatt GR, et al. Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proc Natl Acad Sci U S A. 2009;106(20):8314-8319.
43. Apcher S, Daskalogianni C, Lejeune F, et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A. 2011;108(28):11572-11577.
44. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102-114.
45. Hendrickson DG, Hogan DJ, McCullough HL, et al. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 2009;7(11): e1000238.
46. Guo S, Lu J, Schlanger R, et al. MicroRNA miR- 125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A. 2010;107(32):14229- 14234.
47. Visone R, Veronese A, Rassenti LZ, et al. miR- 181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 2011; 118(11):3072-3079.
48. Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol. 2011;18(4):266-272.
49. O'Connell RM, Zhao JL, Rao DS. MicroRNA function in myeloid biology. Blood. 2011;118(11):2960-2969.